
Jason A. Deck
Examiner (ID: 427)
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627 |
| Total Applications | 619 |
| Issued Applications | 298 |
| Pending Applications | 2 |
| Abandoned Applications | 319 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 13/992137 | PHARMACEUTICAL COMPOSITION COMPRISING TRANS-CINNAMALDEHYDE AND ITS USE IN THE TREATMENT OF INFECTIONS | Aug 20, 2013 | Abandoned |
Array
(
[id] => 9198815
[patent_doc_number] => 20130338130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 13/970524
[patent_app_country] => US
[patent_app_date] => 2013-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 38167
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13970524
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/970524 | METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS | Aug 18, 2013 | Abandoned |
Array
(
[id] => 10346087
[patent_doc_number] => 20150231092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'NOVEL EFFERVESCENT SACHET FORMULATIONS OF DAPOXETINE AND A PDE5 INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 14/421333
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3886
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421333
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/421333 | NOVEL EFFERVESCENT SACHET FORMULATIONS OF DAPOXETINE AND A PDE5 INHIBITOR | Aug 14, 2013 | Abandoned |
Array
(
[id] => 12044547
[patent_doc_number] => 09822139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Pharmaceutical composition containing cyclometalated N-heterocyclic carbene complexes for cancer treatment'
[patent_app_type] => utility
[patent_app_number] => 13/960986
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13655
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960986
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/960986 | Pharmaceutical composition containing cyclometalated N-heterocyclic carbene complexes for cancer treatment | Aug 6, 2013 | Issued |
Array
(
[id] => 9149053
[patent_doc_number] => 20130303576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'ENZYME INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/946488
[patent_app_country] => US
[patent_app_date] => 2013-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18120
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946488
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/946488 | ENZYME INHIBITORS | Jul 18, 2013 | Abandoned |
Array
(
[id] => 11778158
[patent_doc_number] => 09387193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-12
[patent_title] => 'Composition comprising scirpusin A and scirpusin B and anti-adipogenesis/anti-obesity potential thereof'
[patent_app_type] => utility
[patent_app_number] => 13/944634
[patent_app_country] => US
[patent_app_date] => 2013-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10509
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944634
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/944634 | Composition comprising scirpusin A and scirpusin B and anti-adipogenesis/anti-obesity potential thereof | Jul 16, 2013 | Issued |
Array
(
[id] => 12111400
[patent_doc_number] => 09867373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'Fungicidal composition having synergistic effect'
[patent_app_type] => utility
[patent_app_number] => 14/889924
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13252
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14889924
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/889924 | Fungicidal composition having synergistic effect | Jun 12, 2013 | Issued |
| 13/906155 | Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate | May 29, 2013 | Abandoned |
Array
(
[id] => 9042479
[patent_doc_number] => 20130245117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'NOVEL USE OF CAPSIATE OR DIHYDROCAPSIDATE'
[patent_app_type] => utility
[patent_app_number] => 13/889808
[patent_app_country] => US
[patent_app_date] => 2013-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14130
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13889808
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/889808 | Use of capsiate or dihydrocapsidate | May 7, 2013 | Issued |
Array
(
[id] => 10920424
[patent_doc_number] => 20140323444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'ANTI-INFLAMMATORY AND ANTIDIABETIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/869117
[patent_app_country] => US
[patent_app_date] => 2013-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3536
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13869117
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/869117 | ANTI-INFLAMMATORY AND ANTIDIABETIC AGENTS | Apr 23, 2013 | Abandoned |
Array
(
[id] => 9095020
[patent_doc_number] => 20130274331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'Method for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halofenic Acid and an Anti-Inflammatory Agent'
[patent_app_type] => utility
[patent_app_number] => 13/862262
[patent_app_country] => US
[patent_app_date] => 2013-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13016
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13862262
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/862262 | Method for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halofenic Acid and an Anti-Inflammatory Agent | Apr 11, 2013 | Abandoned |
Array
(
[id] => 15911845
[patent_doc_number] => 10653137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Arthropod pest control composition and method
[patent_app_type] => utility
[patent_app_number] => 13/858281
[patent_app_country] => US
[patent_app_date] => 2013-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4229
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858281
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/858281 | Arthropod pest control composition and method | Apr 7, 2013 | Issued |
Array
(
[id] => 9739326
[patent_doc_number] => 20140275045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/838372
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24085
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13838372
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/838372 | PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9436024
[patent_doc_number] => 20140113931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'SUBSTITUTED PICOLINAMIDE KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/841867
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21282
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13841867
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/841867 | SUBSTITUTED PICOLINAMIDE KINASE INHIBITORS | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9739241
[patent_doc_number] => 20140274961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'Compounds and uses thereof for the modulation of hemoglobin'
[patent_app_type] => utility
[patent_app_number] => 13/815810
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8684
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13815810
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/815810 | Compounds and uses thereof for the modulation of hemoglobin | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9739462
[patent_doc_number] => 20140275181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'Compounds and uses thereof for the modulation of hemoglobin'
[patent_app_type] => utility
[patent_app_number] => 13/815874
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10145
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13815874
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/815874 | Compounds and uses thereof for the modulation of hemoglobin | Mar 14, 2013 | Issued |
Array
(
[id] => 9081972
[patent_doc_number] => 20130267502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/835607
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 79459
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13835607
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/835607 | Treatment of addiction and impulse-control disorders using PDE7 inhibitors | Mar 14, 2013 | Issued |
Array
(
[id] => 12036517
[patent_doc_number] => 09814729
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Nerve agent antidotes'
[patent_app_type] => utility
[patent_app_number] => 13/830615
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13321
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830615
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/830615 | Nerve agent antidotes | Mar 13, 2013 | Issued |
Array
(
[id] => 9122355
[patent_doc_number] => 20130289277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'MEDICAMENT FOR TREATING MENTAL AND BEHAVIOURAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/827655
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6925
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13827655
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/827655 | Medicament for treating mental and behavioural disorders | Mar 13, 2013 | Issued |
Array
(
[id] => 9397050
[patent_doc_number] => 20140094456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'ANTI-FIBROTIC PYRIDINONES'
[patent_app_type] => utility
[patent_app_number] => 13/799727
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 97666
[patent_no_of_claims] => 165
[patent_no_of_ind_claims] => 95
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13799727
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/799727 | ANTI-FIBROTIC PYRIDINONES | Mar 12, 2013 |